SAN DIEGO, Feb. 25, 2016 /PRNewswire/ -- Experts from Pharmatek, a leading contract development and manufacturing organization supporting the pharmaceutical industry, will discuss strategies for early stage formulation and process development of poorly soluble compounds at a seminar next month. The event, “Product Development Strategies for Poorly Soluble Compounds Adding Value with Spray Dried Dispersions,” will be held Tuesday, March 15, 2016, at the Hilton Short Hills New Jersey from 12:00 p.m. to 5:00 p.m.
Experts will provide attendees with key strategies for the development of poorly soluble compounds through the utilization of spray drying and other bioavailability enhancement technologies. Presentations include:
- “Data Driven Formulation Development”
Presented by Bryan Knox, senior director, pharmaceutics at Pharmatek. Mr. Knox will discuss multiple formulation options enabling first-in-human clinical studies. - “Spray Dried Dispersion Formulation Development for Early Phase Clinical Studies”
Presented by Nathan Barksdale, senior scientist at Pharmatek. Mr. Barksdale will present best practices for formulation screening and evaluation of stability, performance and manufacturability of spray dried dispersions. - “Spray Dried Dispersion Process Development”
Presented by Jon Scrafford, manager, process engineering at Pharmatek. Mr. Scrafford will highlight scalability as a key factor for spray dried dispersions.
For more information and to register, please visit www.pharmatek.com.
Pharmatek has more than sixteen years of experience working with pharmaceutical companies to advance their early stage drug candidates by focusing on efficient dosage form development and GMP manufacturing solutions. The Company’s expertise has helped deliver effective treatments, while reducing overall project cost and time-to-clinic with a high level of quality and customer service.
About Pharmatek
Pharmatek is a dosage form development and GMP manufacturing company providing full-service pharmaceutical chemistry product development and manufacturing for the pharmaceutical industry. Pharmatek focuses on bringing client compounds from discovery to the clinic with services that include compound selection, analytical development, preformulation testing, formulation development, GMP manufacturing, stability storage and testing, clinical packaging, labeling and distribution, and cytotoxic and high-potency drug development.
Statements contained in this media release which are not historical facts may constitute forward-looking statements. All forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from those projected including sales forecasts and strategic expansion. The trademarks Pharmatek, Pharmatek Laboratories, Inc., Hot Rod Chemistry, Pharmatek Formulation Screening, Pharmatek University and PTEK U are all property of Pharmatek Laboratories, Inc. Additional information about Pharmatek may be obtained at the website http://www.pharmatek.com or by calling 858-805-6383.
Company Contact:
Elizabeth Hickman, Director, Sales and Marketing
Pharmatek Laboratories, Inc.
(619) 772-9555 or ehickman@pharmatek.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pharmatek-to-highlight-solubility-solutions-at-new-jersey-seminar-300226730.html
SOURCE Pharmatek
